DXRX.L

Diaceutics PLC · Healthcare · Diagnostics & Research

Earnings call summary →

—

Loading quote…

Highlights

Market Cap

$8.41B

PE Ratio

EV to Ebitda

19.0893

Earnings Yield

116345.55%

Revenue (TTM)

$18.7M

Net Income (TTM)

$0.16M

Revenue (Annual YoY Growth)

—

Revenue (Quarterly YoY Growth)

26.20%

Profit Margin

0.83%

Return on Equity

—

Debt to Equity Ratio

—

Dividend Yield

0.00%

All fundamentals

Core6 fields›

Market Cap$8.41B

Revenue TTM$18.7M

Shares Outstanding84.5M

Float50204653

Insider Ownership46.90%

Institutional Ownership47.72%

Growth Estimates5 fields›

Revenue Growth (Quarterly YoY)26.20%

Rev Growth Est 1Y Forward0.2000

EPS Growth (Quarterly YoY)-13.30%

EPS Growth Est Quarterly0

LT EPS Growth Estimates-581.60%

Operations13 fields›

Revenue TTM$18.7M

Gross Margin TTM69.22%

Operating Margin TTM0.12%

Profit Margin TTM0.83%

Net Income TTM$0.16M

EPS TTM0

EBIT Margin TTM8.06%

EBITDA TTM$1.5M

CFO % of Revenue TTM16.39%

CFO TTM$3.1M

Capex % of Revenue TTM2.22%

Capital Expenditures$0.41M

FCF % of Revenue (Quarterly)-32.45%

Efficiency1 fields›

ROA0.03%

Valuation8 fields›

P/E (TTM)0

P/E Forward19.7239

P/FCF-0.00002203868197781753

EV/EBITDA (TTM)19.0893

EV/Revenues (TTM)2.8896

Earnings Yield116345.55%

Dividend Yield0.00%

Payout Ratio0.00%

Liquidity5 fields›

Cash Per Share0.2527919635719521

Current Ratio11.413059984813971

Total Assets$45.53T

Shareholders Equity$40.95T

Interest Expense$0.15M

Yields3 fields›

Dividend Yield0.00%

Payout Ratio0.00%

Earnings Yield116345.55%